Characterizing Benzo[a]pyrene-induced lacZ mutation spectrum in transgenic mice using next-generation sequencing
- DOI
- Language of the publication
- English
- Date
- 2015-10-19
- Type
- Article
- Author(s)
- Beal, Marc A.
- Gagné, Rémi
- Williams, Andrew
- Marchetti, Francesco
- Yauk, Carole L.
- Publisher
- BMC
Abstract
Background The transgenic rodent mutation reporter assay provides an efficient approach to identify mutagenic agents in vivo. A major advantage of this assay is that mutant reporter transgenes can be sequenced to provide information on the mode of action of a mutagen and to identify clonally expanded mutations. However, conventional DNA sequence analysis is laborious and expensive for long transgenes, such as lacZ (3096 bp), and is not normally implemented in routine screening. Methods We developed a high-throughput next-generation sequencing (NGS) approach to simultaneously sequence large numbers of barcoded mutant lacZ transgenes from different animals. We collected 3872 mutants derived from the bone marrow DNA of six Muta™Mouse males exposed to the well-established mutagen benzo[a]pyrene (BaP) and six solvent-exposed controls. Mutants within animal samples were pooled, barcoded, and then sequenced using NGS. Results We identified 1652 mutant sequences from 1006 independent mutations that underwent clonal expansion. This deep sequencing analysis of mutation spectrum demonstrated that BaP causes primarily guanine transversions (e.g. G:C → T:A), which is highly consistent with previous studies employing Sanger sequencing. Furthermore, we identified novel mutational hotspots in the lacZ transgene that were previously uncharacterized by Sanger sequencing. Deep sequencing also allowed for an unprecedented ability to correct for clonal expansion events, improving the sensitivity of the mutation reporter assay by 50 %. Conclusion These results demonstrate that the high-throughput nature and reduced costs offered by NGS provide a sensitive and fast approach for elucidating and comparing mutagenic mechanisms of various agents among tissues and enabling improved evaluation of genotoxins.
Plain language summary
Health Canada helps to protect the health of Canadians by assessing and managing the health risks associated with chemical exposures. Exposures to certain chemicals can induce different types of DNA damage that can cause mutations, and these genetic alterations can potentially lead to the progression of diseases such as cancer. Therefore, it is important to characterize the types of mutations induced by chemicals in order to understand the mechanisms by which they may promote disease. For this reason, Health Canada developed a cost-effective and time-saving method to study the types of mutations induced by chemical exposure. The method uses a well-established genetically modified mouse strain (called Muta™Mouse) that is routinely used to determine the number of mutations induced following a particular exposure. With this improved method, mutations isolated with the Muta™Mouse test are subject to DNA sequence analysis using high-throughput next generation sequencing methodologies that allow the sequencing of tens of thousands of DNA sequences simultaneously. Proof of principle was demonstrated by sequencing the bone marrow DNA of mice exposed to benzo[a]pyrene (BaP), a known mutagenic carcinogen that induces predictable changes in DNA sequence. The results showed that this new method is much faster and more cost-effective than existing methods, and provides accurate information on the types of mutations that occur. It is envisioned that this method will be routinely used in the future to investigate the harmful effects of other chemicals and provide information on the mechanisms underlying toxicological effects.
Subject
- Health,
- Health and safety